Literature DB >> 26613735

Brain Angiotensin II AT1 receptors are involved in the acute and long-term amphetamine-induced neurocognitive alterations.

Natalia Andrea Marchese1, Emilce Artur de laVillarmois1, Osvaldo Martin Basmadjian1, Mariela Fernanda Perez2, Gustavo Baiardi3, Claudia Bregonzio1.   

Abstract

RATIONALE: Angiotensin II, by activation of its brain AT1-receptors, plays an active role as neuromodulator in dopaminergic transmission. These receptors participate in the development of amphetamine-induced behavioral and dopamine release sensitization. Dopamine is involved in cognitive processes and provides connectivity between brain areas related to these processes. Amphetamine by its mimetic activity over dopamine neurotransmission elicits differential responses after acute administration or after re-exposure following long-term withdrawal periods in different cognitive processes.
OBJECTIVE: The purpose of this study is to evaluate the AT1-receptor involvement in the acute and long-term amphetamine-induced alterations in long-term memory and in cellular-related events.
METHODS: Male Wistar rats (250-300 g) were used in this study. Acute effects: Amphetamine (0.5/2.5 mg/kg i.p.) was administered after post-training in the inhibitory avoidance (IA) response. The AT1-receptor blocker Losartan was administered i.c.v. before a single dose of amphetamine (0.5 mg/kg i.p.). Long-term effects: The AT1-receptors blocker Candesartan (3 mg/kg p.o.) was administered for 5 days followed by 5 consecutive days of amphetamine (2.5 mg/kg/day, i.p.). The neuroadaptive changes were evidenced after 1 week of withdrawal by an amphetamine challenge (0.5 mg/kg i.p.). The IA response, the neuronal activation pattern, and the hippocampal synaptic transmission were evaluated.
RESULTS: The impairing effect in the IA response of post-training acute amphetamine was partially prevented by Losartan. The long-term changes induced by repeated amphetamine (resistance to acute amphetamine interference in the IA response, neurochemical altered response, and increased hippocampal synaptic transmission) were prevented by AT1-receptors blockade.
CONCLUSIONS: AT1-receptors are involved in the acute alterations and in the neuroadaptations induced by repeated amphetamine associated with neurocognitive processes.

Entities:  

Keywords:  AT1 receptors; Amphetamine; Angiotensin II; Candesartan; FOS; Hippocampus; Inhibitory avoidance; Long-term memory; Long-term potentiation; Losartan

Mesh:

Substances:

Year:  2015        PMID: 26613735     DOI: 10.1007/s00213-015-4153-1

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  67 in total

1.  Strain-dependent effects of post-training dopamine receptor agonists and antagonists on memory storage in mice.

Authors:  V Cestari; C Castellano; S Cabib; S Puglisi-Allegra
Journal:  Behav Neural Biol       Date:  1992-07

2.  Differential contribution of amygdala and hippocampus to cued and contextual fear conditioning.

Authors:  R G Phillips; J E LeDoux
Journal:  Behav Neurosci       Date:  1992-04       Impact factor: 1.912

3.  Post-training dopamine receptor agonists and antagonists affect memory storage in mice irrespective of their selectivity for D1 or D2 receptors.

Authors:  C Castellano; V Cestari; S Cabib; S Puglisi-Allegra
Journal:  Behav Neural Biol       Date:  1991-11

Review 4.  Stimulus-transcription coupling in the nervous system: involvement of the inducible proto-oncogenes fos and jun.

Authors:  J I Morgan; T Curran
Journal:  Annu Rev Neurosci       Date:  1991       Impact factor: 12.449

5.  The counting Stroop: an interference task specialized for functional neuroimaging--validation study with functional MRI.

Authors:  G Bush; P J Whalen; B R Rosen; M A Jenike; S C McInerney; S L Rauch
Journal:  Hum Brain Mapp       Date:  1998       Impact factor: 5.038

Review 6.  Long-term potentiation.

Authors:  T J Teyler; P DiScenna
Journal:  Annu Rev Neurosci       Date:  1987       Impact factor: 12.449

7.  Nigral and striatal regulation of angiotensin receptor expression by dopamine and angiotensin in rodents: implications for progression of Parkinson's disease.

Authors:  Begoña Villar-Cheda; Jannette Rodríguez-Pallares; Rita Valenzuela; Ana Muñoz; Maria J Guerra; Ovidiu C Baltatu; Jose L Labandeira-Garcia
Journal:  Eur J Neurosci       Date:  2010-10-21       Impact factor: 3.386

8.  Endogenous brain angiotensin II disrupts passive avoidance behavior in rats.

Authors:  M Köller; H P Krause; F Hoffmeister; D Ganten
Journal:  Neurosci Lett       Date:  1979-09       Impact factor: 3.046

Review 9.  Mapping tissue angiotensin-converting enzyme and angiotensin AT1, AT2 and AT4 receptors.

Authors:  J Zhuo; I Moeller; T Jenkins; S Y Chai; A M Allen; M Ohishi; F A Mendelsohn
Journal:  J Hypertens       Date:  1998-12       Impact factor: 4.844

10.  Anxiolytic-like effect of losartan injected into amygdala of the acutely stressed rats.

Authors:  Luis H Llano López; Fernando Caif; Sebastián García; Miriam Fraile; Adriana I Landa; Gustavo Baiardi; José V Lafuente; Jan J Braszko; Claudia Bregonzio; Pascual A Gargiulo
Journal:  Pharmacol Rep       Date:  2012       Impact factor: 3.024

View more
  5 in total

1.  Prenatal Amphetamine-Induced Dopaminergic Alteration in a Gender- and Estrogen-Dependent Manner.

Authors:  C Bregonzio; M Soaje; G E Pennacchio; F E Santonja; F J Neira
Journal:  Neurochem Res       Date:  2022-02-11       Impact factor: 3.996

2.  Angiotensin II-mediated suppression of synaptic proteins in mouse hippocampal neuronal HT22 cell was inhibited by propofol: role of calcium signaling pathway.

Authors:  Xiaowei Ding; Xingzhu Ju; Yan Lu; Wei Chen; Jiaqiang Wang; Changhong Miao; Jiawei Chen
Journal:  J Anesth       Date:  2018-10-06       Impact factor: 2.078

3.  Angiotensin II Type 1 Receptor Blockers Inhibit KAT II Activity in the Brain-Its Possible Clinical Applications.

Authors:  Izabela Zakrocka; Katarzyna M Targowska-Duda; Artur Wnorowski; Tomasz Kocki; Krzysztof Jóźwiak; Waldemar A Turski
Journal:  Neurotox Res       Date:  2017-07-21       Impact factor: 3.911

Review 4.  Recent Advances in the Endogenous Brain Renin-Angiotensin System and Drugs Acting on It.

Authors:  Aswar Urmila; Patil Rashmi; Ghag Nilam; Bodhankar Subhash
Journal:  J Renin Angiotensin Aldosterone Syst       Date:  2021-11-30       Impact factor: 1.636

Review 5.  Within the Brain: The Renin Angiotensin System.

Authors:  LaDonya Jackson; Wael Eldahshan; Susan C Fagan; Adviye Ergul
Journal:  Int J Mol Sci       Date:  2018-03-15       Impact factor: 5.923

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.